An update on the burden of group A streptococcal diseases in Australia and vaccine development

Jeffrey W Cannon and Asha C Bowen
Med J Aust 2021; 215 (1): . || doi: 10.5694/mja2.51126
Published online: 5 July 2021

National surveillance would facilitate strategies for preventing or managing conditions that predispose people to severe streptococcal disease

  • Jeffrey W Cannon1,2
  • Asha C Bowen1,3

  • 1 Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA
  • 2 Harvard T. H. Chan School of Public Health, Boston, MA, United States of America
  • 3 Perth Children’s Hospital, Perth, WA

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.